Type 1 diabetes mellitus: genes and variants
Explore variant evidence for Type 1 diabetes mellitus across 13 analyzed proteins (INS, IL2RA, BACH2, CD3E, CTLA4 and 8 more). Linked ClinVar records include 8 pathogenic or likely pathogenic variants, 9 variants of uncertain significance and 3 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Source labels are pooled across this disease family.
Data updated 2026-10-21. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Type 1 diabetes mellitus
INS: Insulin
After processing to insulin, it lowers blood glucose by promoting cellular glucose uptake, glycogen and lipid synthesis, and suppression of hepatic glucose production. Pathogenic variants can cause neonatal diabetes, maturity-onset diabetes of the young, or hyperproinsulinemia depending on their effect on folding and secretion.
8 ClinVar pathogenic / likely pathogenic and 7 uncertain variants in INS have source records linked to Type 1 diabetes mellitus. Association strength is not clinical gene validity.
IL2RA: Interleukin-2 receptor subunit alpha
It contributes to the high-affinity IL-2 receptor on activated T cells and regulatory T cells, supporting lymphocyte proliferation and immune tolerance. Loss-of-function variants can cause immunodeficiency with autoimmunity, while abnormal expression is therapeutically targeted in selected immune disorders.
0 ClinVar pathogenic / likely pathogenic and 2 uncertain variants in IL2RA have source records linked to Type 1 diabetes mellitus. Association strength is not clinical gene validity.
BACH2: Transcription regulator protein BACH2
It controls transcriptional programs that balance lymphocyte differentiation, immune tolerance, and effector-cell development. Haploinsufficiency can cause immunodeficiency with autoimmunity, and common variation influences susceptibility to several autoimmune diseases.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in BACH2 have source records linked to Type 1 diabetes mellitus. Association strength is not clinical gene validity.
CD3E: T-cell surface glycoprotein CD3 epsilon chain
It helps assemble the T-cell receptor complex and transduces antigen-recognition signals through its cytoplasmic signaling motifs. Biallelic pathogenic variants can impair T-cell development and cause severe combined immunodeficiency.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in CD3E have source records linked to Type 1 diabetes mellitus. Association strength is not clinical gene validity.
CTLA4: Cytotoxic T-lymphocyte protein 4
It restrains T-cell activation by competing with CD28 for CD80 and CD86 and by delivering inhibitory signals after immune activation. Haploinsufficiency causes immune dysregulation with autoimmunity and lymphoproliferation, while therapeutic blockade enhances antitumor immunity.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in CTLA4 have source records linked to Type 1 diabetes mellitus. Association strength is not clinical gene validity.
FOXP3: Forkhead box protein P3
It establishes the transcriptional program of regulatory T cells and is essential for maintaining peripheral immune tolerance. Loss-of-function variants cause IPEX syndrome with severe early-onset autoimmunity, enteropathy, eczema, and endocrine disease.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in FOXP3 have source records linked to Type 1 diabetes mellitus. Association strength is not clinical gene validity.
IL10: Interleukin-10
It suppresses excessive inflammatory cytokine production and restrains antigen-presenting cells and effector lymphocytes, protecting tissues from immune-mediated damage. Loss of IL-10 signaling causes severe early-onset intestinal inflammation and inflammatory bowel disease.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in IL10 have source records linked to Type 1 diabetes mellitus. Association strength is not clinical gene validity.
INSR: Insulin receptor
Its activation by insulin coordinates glucose uptake, metabolism, growth, and gene expression through PI3K-AKT and MAPK pathways. Biallelic severe loss-of-function variants cause Donohue or Rabson-Mendenhall syndromes, while heterozygous variants can cause severe insulin resistance.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in INSR have source records linked to Type 1 diabetes mellitus. Association strength is not clinical gene validity.
PTPN22: Tyrosine-protein phosphatase non-receptor type 22
It tunes antigen-receptor signaling thresholds in T and B cells and helps maintain immune tolerance. The common R620W variant is a major non-HLA genetic risk factor for several autoimmune diseases, including type 1 diabetes and rheumatoid arthritis.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in PTPN22 have source records linked to Type 1 diabetes mellitus. Association strength is not clinical gene validity.
SH2B3: SH2B adapter protein 3
It restrains cytokine and growth-factor signaling in hematopoietic cells, including JAK-STAT pathways controlling blood-cell production. Loss-of-function variants can increase blood-cell proliferation and predispose to myeloproliferative neoplasms, while common variants influence autoimmune and hematologic traits.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in SH2B3 have source records linked to Type 1 diabetes mellitus. Association strength is not clinical gene validity.
SLC5A2: Sodium/glucose cotransporter 2
It reabsorbs most filtered glucose from the renal proximal tubule together with sodium. Loss-of-function variants cause familial renal glucosuria, while pharmacologic inhibition lowers blood glucose and provides major cardiovascular and kidney benefits.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in SLC5A2 have source records linked to Type 1 diabetes mellitus. Association strength is not clinical gene validity.
TCF7L2: Transcription factor 7-like 2
It mediates Wnt-dependent transcription and also influences pancreatic, hepatic, and intestinal programs involved in glucose metabolism. Common intronic variants at this locus are among the strongest and most reproducible genetic risk factors for type 2 diabetes.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in TCF7L2 have source records linked to Type 1 diabetes mellitus. Association strength is not clinical gene validity.
TYK2: Non-receptor tyrosine-protein kinase TYK2
It transmits signals from type I interferon, IL-12, IL-23, and related cytokine receptors. Severe loss-of-function can cause immunodeficiency, common variants influence autoimmune susceptibility, and partial pharmacologic inhibition is effective in inflammatory disease.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in TYK2 have source records linked to Type 1 diabetes mellitus. Association strength is not clinical gene validity.
Weakly linked (only a few uncertain records): CCR5, KCNJ11 and LIPC.
ClinVar pathogenic and likely pathogenic variants linked to Type 1 diabetes mellitus
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| INS C96S | 96 | Pathogenic / likely pathogenic (★★) | |
| INS C96F | 96 | Pathogenic / likely pathogenic (★★) | |
| INS C96R | 96 | Pathogenic / likely pathogenic (★★) | |
| INS C96Y | 96 | Pathogenic / likely pathogenic (★★) | |
| INS M1V | 1 | Pathogenic / likely pathogenic (★★) | |
| INS R89L | 89 | Pathogenic / likely pathogenic | |
| INS R89H | 89 | Pathogenic / likely pathogenic | |
| INS R89P | 89 | Pathogenic / likely pathogenic |
Which prediction tools work for Type 1 diabetes mellitus
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- ESM1b (LLR): 95 out of 100
- AlphaMissense: 94 out of 100
Same protein, different disease
- Diabetes mellitus also has ClinVar records linked to INS variants; they fall mostly in different places as the Type 1 diabetes mellitus variants (12 pathogenic / likely pathogenic).
- Diabetes mellitus, permanent also has ClinVar records linked to INS variants; they fall mostly in different places as the Type 1 diabetes mellitus variants (11 pathogenic / likely pathogenic).
- Maturity-onset diabetes of the young also has ClinVar records linked to INS variants; they fall mostly in different places as the Type 1 diabetes mellitus variants (3 pathogenic / likely pathogenic).
Diseases related to Type 1 diabetes mellitus
- Diabetes mellitus, also linked to INS, INSR, PTPN22, SLC5A2 and 1 more
- Hypothyroidism, also linked to BACH2, CTLA4, PTPN22, SH2B3 and 1 more
- Type 2 diabetes mellitus, also linked to INS, INSR, SLC5A2 and TCF7L2
- Systemic lupus erythematosus, also linked to CTLA4, IL10, PTPN22 and TYK2
- Crohn disease, also linked to IL10, PTPN22 and TYK2
- Monogenic diabetes, also linked to INS and INSR
- Inflammatory bowel disease, also linked to BACH2 and IL10
- Basal cell carcinoma, also linked to BACH2 and CTLA4
- Renal cell carcinoma, also linked to CTLA4 and IL2RA
- Maturity-onset diabetes of the young, also linked to INS
- Diabetes mellitus, permanent, also linked to INS
- Colorectal cancer, also linked to TCF7L2
Frequently asked questions
Which genes have records linked to Type 1 diabetes mellitus?
This view contains 13 analyzed proteins: INS, IL2RA, BACH2, CD3E, CTLA4 and 8 more. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 8 pathogenic or likely pathogenic variants, 9 variants of uncertain significance and 3 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 20 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center